BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH – Get Free Report) was the recipient of a significant growth in short interest during the month of September. As of September 15th, there was short interest totaling 7,084 shares, a growth of 769.2% from the August 31st total of 815 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 48,995 shares, the days-to-cover ratio is currently 0.1 days.
BioForce Nanosciences Trading Up 1.7%
Shares of BFNH traded up $0.16 on Friday, reaching $9.35. The company’s stock had a trading volume of 429 shares, compared to its average volume of 8,486. BioForce Nanosciences has a twelve month low of $0.18 and a twelve month high of $10.99. The stock has a market capitalization of $355.86 million, a PE ratio of 935.69 and a beta of -0.31. The firm has a fifty day moving average of $4.44 and a 200-day moving average of $2.18.
BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) last released its quarterly earnings results on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter.
BioForce Nanosciences Company Profile
BioForce Nanosciences is a nanotechnology company that developed instrumentation, consumables and related technologies for life sciences research and nanoscale surface engineering. Its products were designed to help researchers manipulate very small volumes of liquids and create controlled patterns of biological or chemical materials on surfaces.
The company’s best-known technology was the Nano eNabler platform, also described as a molecular printer. The system used specialized dispensing tools to deposit precise quantities of fluids, enabling applications such as biomolecular patterning, microarray fabrication, cell-based research and other laboratory experiments involving nanoscale structures.
BioForce Nanosciences served research institutions, biotechnology companies and other organizations working in nanotechnology and the life sciences.
See Also
- Five stocks we like better than BioForce Nanosciences
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
- BlackBerry Shifts Gears With Coretura Deal
- NVIDIA’s Next AI Chip Ramp Could Open the Door to Another Major Stock Move
- Super Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the Test
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
